Guideline statin eligibility and coronary risk, cost-effectiveness of coronary risk thresholds, patiromer for hyperkalemia, managing polypharmacy, and more.
- Author
- American Medical Association
- Published
- Tue 14 Jul 2015
- Episode Link
- http://dx.doi.org/10.1001/jama.2014.11851
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 14, 2015 issue
